logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

China Reading Limited (00772.HK) issued approximately 24,600 shares by exercising its stock purchase rights.

date
17/09/2025
The Sina Finance app reported that Tencent has announced that on September 17, 2025, it will issue approximately 24,600 shares at an issue price of HK$32.06 per share due to the exercise of stock options.
Latest
2 m ago
Vanke recently underwent its largest-scale organizational restructuring in recent years, focusing on streamlining and strengthening centralization of its headquarters.
3 m ago
Joint Information: Insider information about the 2025 incentive plan has been released for the stock trading self-inspection results.
3 m ago
In August, non-banking financial institutions in Shanghai saw an increase of 278 billion yuan in deposits, a year-on-year increase of 285.8 billion yuan.
4 m ago
Silicon Industry Branch: Tight supply of polycrystalline silicon supports continued price increase trend, new energy consumption standards reconstruct supply and demand structure.
4 m ago
Bristol-Myers Squibb to sell 60% stake in the first Sino-American joint venture pharmaceutical company.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.